concurrent temozolomide

DRUG2 trials

Sponsors

Radiation Therapy Oncology Group

Conditions

Brain and Central Nervous System Tumors

Phase 1

Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

CompletedNCT01062399

Radiation Therapy Oncology GroupBrain and Central Nervous System Tumors

Start: 2010-12-31End: 2022-05-20Updated: 2022-06-09

Phase 3

Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

CompletedNCT00304031

Radiation Therapy Oncology GroupBrain and Central Nervous System Tumors

Start: 2006-01-31End: 2016-12-31Updated: 2020-06-09

Related Papers

Are we providing best-available care to newly diagnosed glioblastoma patients? Systematic review of phase III trials in newly diagnosed glioblastoma 2005-2022.

2023-01-0112 citations

Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era

JAMA Oncology2017-01-1795 citations